jueves, 9 de enero de 2014

A.D.H.D. Experts Re-evaluate Study’s Zeal for Drugs - NYTimes.com

A.D.H.D. Experts Re-evaluate Study’s Zeal for Drugs - NYTimes.com:

 Twenty years ago, more than a dozen leaders in child psychiatry received $11 million from the National Institute of Mental Health to study an important question facing families with children with attention deficit hyperactivity disorder: Is the best long-term treatment medication, behavioral therapy or both?

 

Ramin Rahimian for The New York Times
Stephen Hinshaw, a University of California, Berkeley, researcher in an influential 1990s study, said skills training should be a priority in A.D.H.D. cases.